HK Stock MarketDetailed Quotes

REMEGEN (09995)

Watchlist
  • 100.600
  • +0.500+0.50%
Market Closed Apr 30 16:08 CST
56.79BMarket Cap38.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

REMEGEN (09995) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
24.76%656.21M
89.55%3.24B
42.27%1.72B
47.63%1.09B
59.17%525.97M
58.92%1.71B
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
Operating income
24.76%656.21M
89.55%3.24B
42.27%1.72B
47.63%1.09B
59.17%525.97M
58.92%1.71B
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
Cost of sales
----
-24.13%-425.51M
----
-0.51%-170.13M
----
-35.42%-342.8M
----
-64.89%-169.27M
----
6.22%-253.14M
Operating expenses
-32.86%-116.96M
-24.13%-425.51M
-10.56%-270.59M
-0.51%-170.13M
-18.39%-88.03M
-35.42%-342.8M
-37.65%-244.74M
-64.89%-169.27M
-196.17%-74.36M
6.22%-253.14M
Gross profit
23.14%539.26M
105.95%2.82B
50.32%1.45B
61.62%921.85M
71.02%437.94M
66.14%1.37B
62.95%964.13M
80.26%570.39M
78.91%256.08M
65.31%822.99M
Selling expenses
-9.63%-274.85M
-17.15%-1.11B
-32.11%-822.66M
-34.93%-525.78M
-33.70%-250.7M
-22.39%-948.76M
-15.36%-622.7M
-11.28%-389.67M
-18.81%-187.5M
-75.90%-775.19M
Administrative expenses
10.82%-80.42M
-9.08%-362.44M
8.10%-215.62M
0.55%-154.36M
-21.44%-90.18M
-5.93%-332.28M
3.39%-234.62M
7.94%-155.22M
5.70%-74.26M
-15.09%-313.67M
Research and development expenses
36.19%-209.86M
20.85%-1.22B
22.79%-890.58M
19.72%-647.22M
0.69%-328.88M
-17.87%-1.54B
-34.43%-1.15B
-49.18%-806.23M
-32.62%-331.18M
-33.01%-1.31B
Profit from asset sales
-90.46%5.83K
----
132.77%205.69K
----
--61.14K
----
--88.36K
----
----
----
Revaluation surplus
--361.2M
----
-59.11%293.72K
----
----
----
-86.10%718.29K
----
-101.81%-49.46K
----
-Changes in the fair value of other assets
--361.2M
----
-59.11%293.72K
----
----
----
-86.10%718.29K
----
-101.81%-49.46K
----
Impairment and provision
24.98%5.57M
94.81%-576K
76.92%-3.64M
154.07%2.06M
195.64%4.46M
1.67%-11.09M
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-Other impairment is provision
24.98%5.57M
94.81%-576K
76.92%-3.64M
154.07%2.06M
195.64%4.46M
1.67%-11.09M
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
Special items of operating profit
12.96%4.06M
856.98%657.16M
-78.25%14.46M
-111.98%-4.31M
-69.50%3.59M
-27.98%68.67M
87.59%66.48M
-27.46%35.95M
2.19%11.78M
-55.96%95.35M
Operating profit
249.26%339.38M
155.88%780M
52.24%-480.68M
45.53%-407.76M
31.97%-227.38M
6.20%-1.4B
2.21%-1.01B
-7.35%-748.59M
-1.58%-334.24M
-50.00%-1.49B
Financing income
-26.04%1.1M
----
-58.21%3.57M
----
-56.10%1.48M
----
-55.16%8.54M
----
-65.25%3.37M
----
Financing cost
37.25%-13.36M
3.05%-70.17M
-2.59%-57.04M
-31.21%-41.81M
-65.54%-21.29M
-213.45%-72.38M
-307.11%-55.6M
-431.38%-31.87M
-394.46%-12.86M
-241.73%-23.09M
Share of profits of associates
----
642.31%564K
----
----
----
-131.11%-104K
----
----
----
---45K
Special items of earning before tax
61.88%-1.68M
----
13.71%-13.43M
----
-10.70%-4.4M
----
-169.36%-15.56M
----
-147.00%-3.97M
----
Earning before tax
229.25%328.49M
148.38%710.4M
48.60%-550.7M
42.40%-449.57M
27.16%-254.14M
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
Tax
----
---749K
----
----
----
----
----
----
----
----
After-tax profit from continuing operations
229.06%328.01M
148.33%709.65M
48.60%-550.7M
42.40%-449.57M
27.16%-254.14M
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
Earning after tax
229.06%328.01M
148.33%709.65M
48.60%-550.7M
42.40%-449.57M
27.16%-254.14M
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
Profit attributable to shareholders
229.06%328.01M
148.33%709.65M
48.60%-550.7M
42.40%-449.57M
27.16%-254.14M
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
Basic earnings per share
226.09%0.58
147.25%1.29
49.25%-1.01
42.76%-0.83
29.23%-0.46
2.50%-2.73
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
Diluted earnings per share
226.09%0.58
147.25%1.29
49.25%-1.01
42.76%-0.83
29.23%-0.46
2.50%-2.73
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 24.76%656.21M89.55%3.24B42.27%1.72B47.63%1.09B59.17%525.97M58.92%1.71B57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B
Operating income 24.76%656.21M89.55%3.24B42.27%1.72B47.63%1.09B59.17%525.97M58.92%1.71B57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B
Cost of sales -----24.13%-425.51M-----0.51%-170.13M-----35.42%-342.8M-----64.89%-169.27M----6.22%-253.14M
Operating expenses -32.86%-116.96M-24.13%-425.51M-10.56%-270.59M-0.51%-170.13M-18.39%-88.03M-35.42%-342.8M-37.65%-244.74M-64.89%-169.27M-196.17%-74.36M6.22%-253.14M
Gross profit 23.14%539.26M105.95%2.82B50.32%1.45B61.62%921.85M71.02%437.94M66.14%1.37B62.95%964.13M80.26%570.39M78.91%256.08M65.31%822.99M
Selling expenses -9.63%-274.85M-17.15%-1.11B-32.11%-822.66M-34.93%-525.78M-33.70%-250.7M-22.39%-948.76M-15.36%-622.7M-11.28%-389.67M-18.81%-187.5M-75.90%-775.19M
Administrative expenses 10.82%-80.42M-9.08%-362.44M8.10%-215.62M0.55%-154.36M-21.44%-90.18M-5.93%-332.28M3.39%-234.62M7.94%-155.22M5.70%-74.26M-15.09%-313.67M
Research and development expenses 36.19%-209.86M20.85%-1.22B22.79%-890.58M19.72%-647.22M0.69%-328.88M-17.87%-1.54B-34.43%-1.15B-49.18%-806.23M-32.62%-331.18M-33.01%-1.31B
Profit from asset sales -90.46%5.83K----132.77%205.69K------61.14K------88.36K------------
Revaluation surplus --361.2M-----59.11%293.72K-------------86.10%718.29K-----101.81%-49.46K----
-Changes in the fair value of other assets --361.2M-----59.11%293.72K-------------86.10%718.29K-----101.81%-49.46K----
Impairment and provision 24.98%5.57M94.81%-576K76.92%-3.64M154.07%2.06M195.64%4.46M1.67%-11.09M-5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M
-Other impairment is provision 24.98%5.57M94.81%-576K76.92%-3.64M154.07%2.06M195.64%4.46M1.67%-11.09M-5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M
Special items of operating profit 12.96%4.06M856.98%657.16M-78.25%14.46M-111.98%-4.31M-69.50%3.59M-27.98%68.67M87.59%66.48M-27.46%35.95M2.19%11.78M-55.96%95.35M
Operating profit 249.26%339.38M155.88%780M52.24%-480.68M45.53%-407.76M31.97%-227.38M6.20%-1.4B2.21%-1.01B-7.35%-748.59M-1.58%-334.24M-50.00%-1.49B
Financing income -26.04%1.1M-----58.21%3.57M-----56.10%1.48M-----55.16%8.54M-----65.25%3.37M----
Financing cost 37.25%-13.36M3.05%-70.17M-2.59%-57.04M-31.21%-41.81M-65.54%-21.29M-213.45%-72.38M-307.11%-55.6M-431.38%-31.87M-394.46%-12.86M-241.73%-23.09M
Share of profits of associates ----642.31%564K-------------131.11%-104K---------------45K
Special items of earning before tax 61.88%-1.68M----13.71%-13.43M-----10.70%-4.4M-----169.36%-15.56M-----147.00%-3.97M----
Earning before tax 229.25%328.49M148.38%710.4M48.60%-550.7M42.40%-449.57M27.16%-254.14M2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B
Tax -------749K--------------------------------
After-tax profit from continuing operations 229.06%328.01M148.33%709.65M48.60%-550.7M42.40%-449.57M27.16%-254.14M2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B
Earning after tax 229.06%328.01M148.33%709.65M48.60%-550.7M42.40%-449.57M27.16%-254.14M2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B
Profit attributable to shareholders 229.06%328.01M148.33%709.65M48.60%-550.7M42.40%-449.57M27.16%-254.14M2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B
Basic earnings per share 226.09%0.58147.25%1.2949.25%-1.0142.76%-0.8329.23%-0.462.50%-2.73-4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8
Diluted earnings per share 226.09%0.58147.25%1.2949.25%-1.0142.76%-0.8329.23%-0.462.50%-2.73-4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young Huaming Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -